N
Nadeem R. Abu-Rustum
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 552
Citations - 22931
Nadeem R. Abu-Rustum is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Endometrial cancer & Medicine. The author has an hindex of 73, co-authored 471 publications receiving 18517 citations. Previous affiliations of Nadeem R. Abu-Rustum include Rush Medical College & University of Nebraska Medical Center.
Papers
More filters
Journal ArticleDOI
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Wui Jin Koh,Nadeem R. Abu-Rustum,Sarah M. Bean,Kristin A. Bradley,Susana M. Campos,Kathleen R. Cho,Hye Sook Chon,Christina Chu,Rachel M. Clark,David E. Cohn,Marta A. Crispens,Shari Damast,Oliver Dorigo,Patricia J. Eifel,Christine M. Fisher,Peter J. Frederick,David K. Gaffney,Ernest S. Han,Warner K. Huh,John R. Lurain,Andrea Mariani,David G. Mutch,Christa Nagel,Larissa Nekhlyudov,Amanda N. Fader,Steven W. Remmenga,R. Kevin Reynolds,Todd Tillmanns,Stefanie Ueda,Emily Wyse,Catheryn M. Yashar,Nicole R. McMillian,Jillian L. Scavone +32 more
TL;DR: This manuscript discusses guiding principles for the workup, staging, and treatment of early stage and locally advanced cervical cancer, as well as evidence for these recommendations.
Journal ArticleDOI
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)
Dennis S. Chi,Eric L. Eisenhauer,J. Lang,Jae Huh,Lisa B. Haddad,Nadeem R. Abu-Rustum,Yukio Sonoda,Douglas A. Levine,Martee L. Hensley,Richard Barakat +9 more
TL;DR: The data suggest that removal of all evidence of macroscopic disease is associated with prolonged survival and should be the goal of primary cytoreductive surgery, as each incremental decrease in residual disease below 1 cm may be associated with an incremental improvement in overall survival.
Journal ArticleDOI
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Dennis S. Chi,Eric L. Eisenhauer,Oliver Zivanovic,Yukio Sonoda,Nadeem R. Abu-Rustum,Douglas A. Levine,Matthew W. Guile,Robert E. Bristow,Carol Aghajanian,Richard R. Barakat +9 more
TL;DR: The incorporation of extensive upper abdominal procedures resulted in increased optimal cytoreduction rates and significantly improved PFS and OS for patients with advanced ovarian, tubal, and peritoneal carcinomas.
Journal ArticleDOI
Uterine Neoplasms, Version 1.2018: Clinical practice guidelines in oncology
Wui Jin Koh,Nadeem R. Abu-Rustum,Sarah M. Bean,Kristin A. Bradley,Susana M. Campos,Kathleen R. Cho,Hye Sook Chon,Christina Chu,David E. Cohn,Marta A. Crispens,Shari Damast,Oliver Dorigo,Patricia J. Eifel,Christine M. Fisher,Peter J. Frederick,David K. Gaffney,Suzanne George,Ernest S. Han,Susan Higgins,Warner K. Huh,John R. Lurain,Andrea Mariani,David Mutch,Christa Nagel,Larissa Nekhlyudov,Amanda Nickles Fader,Steven W. Remmenga,R. Kevin Reynolds,Todd Tillmanns,Stefanie Ueda,Emily Wyse,Catheryn M. Yashar,Nicole R. McMillian,Jillian L. Scavone +33 more
TL;DR: Guiding principles for the diagnosis, staging, and treatment of early-stage endometrial carcinoma are discussed as well as evidence for these recommendations.
Journal ArticleDOI
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center.
Nadeem R. Abu-Rustum,Kaled M. Alektiar,Alexia Iasonos,Gali Lev,Yukio Sonoda,Carol Aghajanian,Dennis S. Chi,Richard R. Barakat +7 more
TL;DR: Patients undergoing surgery with lymphadenectomy for uterine corpus malignancy should be informed about the possibility of postoperative new symptomatic leg lymphedema, and the incidence, severity, and risk factors of this complication are determined.